Portfolio company
MYOPOWERS MEDICAL TECHNOLOGIES SA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops implantable artificial muscle technology to restore muscle function for patients suffering from conditions such as stress urinary incontinence.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Audaxis Medical
The company develops polyurethane implants to treat stress urinary incontinence in women.
UroMems
UroMems develops an automated implantable electronic artificial urinary sphincter to treat stress urinary incontinence in male and female patients.
MyoPax
This company develops muscle regeneration cell and gene therapies for patients with congenital malformations, trauma, hereditary dystrophies and muscle wasting disorders.
Avation Medical
This company develops non-invasive wearable neuromodulation systems to treat patients suffering from overactive bladder and urinary incontinence.
Amber Therapeutics
This company develops an implantable adaptive neuromodulation system to treat women suffering from mixed urinary incontinence.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Mainstay Medical
This company develops implantable neurostimulation systems for adults suffering from chronic mechanical low back pain caused by muscle dysfunction.
ONWARD Medical
This company develops spinal cord stimulation systems to restore movement and function in people with spinal cord injuries and Parkinson's disease.
